Growth of Bordetella pertussis in Stainer & Scholte medium in which the NaCl had been replaced by one of several inorganic or organic salts resulted in a large decrease in adenylate cyclase activity, histamine-sensitizing activity and in the amounts of two cell-envelope polypeptides of Mr 28000 and 30000. Although some variation between strains was observed, there was never a case where one of these properties was lost independently of the others. Cultures in which these properties were lost had decreased amounts of extracellular cAMP when compared to NaCl-grown cultures. Adenylate cyclase activity was detected in three locations of B. pertussis cultures (extracellular, extracytoplasmic but cell-associated, and cytoplasmic). After growth in medium containing high concentrations of MgSO4, enzyme activity was decreased to a similar extent in all three locations.
BrownlieR. M.,
CooteJ. G.,
PartonR.1984; Adenylate cyclase activity during phenotypic variation of Bordetella pertussis
. Journal of General Microbiology 131:27–38
DobrogoszW. J.,
EzzellJ. W.,
KloosW. E.,
ManclarkC. R.1979; Physiology of Bordetella pertussis
. International Symposium on Pertussis86–93ManclarkC. R.,
HillJ. C.
Washington, DC: US DHEW; Publication no. (NIH) 79-1830
EpsteinW.,
Rothman-DenesL. B.,
HesseJ.1975; Adenosine 3′:5′-cyclic monophosphate as mediator of catabolite repression in Escherichia coli.. Proceedings of the National Academy of Sciences of the United States of America722300–2304
GilmanA. G. A.1970; A protein binding assay for adenosine 3′, 5′-cyclic monophosphate. Proceedings of the National Academy of Sciences of the United States of America67305–312
GoldhammerR.,
WolffJ.,
CookG. H.,
BerkowitzS. A.,
KleeC. B.,
ManclarkC. R.,
HewlettE. L.1981; Spurious protein activators of Bordetella pertussis adenylate cyclase. European Journal of Biochemistry 115:605–609
HewlettE.,
WolffJ.1976; Soluble adenylate cyclase from the culture medium of Bordetella pertussis : purification and characterisation. Journal of Bacteriology 127:890–898
HewlettE. L.,
UrbanM. A.,
ManclarkC. R.,
WolffJ.1976; Extracytoplasmic adenylate cyclase of Bordetella pertussis
. Proceedings of the National Academy of Sciences of the United States of America731926–1930
HewlettE. L.,
UnderhillL. H.,
VargoS. A.,
WolffJ.,
ManclarkC. R.1979a; Bordetella pertussis adenylate cyclase : regulation of activity and its loss in degrading strains. International Symposium on Pertussis81–85ManclarkC. R.,
HillJ. C.
Washington, DC: US DHEW; Publication no. (NIH) 79-1830
HewlettE. L.,
UnderhillL. H.,
CookG. H.,
ManclarkC. R.,
WolffJ.1979b; A protein activator for the adenylate cyclase of Bordetella pertussis
. Journal of Biological Chemistry 254:5602–5605
HoltL. B.,
SpasojevicV.1968; The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intra-cerebral challenge technique in mice. Journal of Medical Microbiology 1:119–126
LiveyI.,
PartonR.,
WardlawA. C.1978; Loss of heat-labile toxin from Bordetella pertussis grown in modified Hornibrook medium. FEMS Microbiology Letters 3:203–205
PittmanM.1979; Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Reviews in Infectious Diseases 1:401–412
StainerD. W.,
ScholteM. J.1971; A simple chemically defined medium for the production of Phase I Bordetella pertussis
. Journal of General Microbiology 63:211–220
WardlawA. C.,
PartonR.1979; Changes in envelope proteins and correlation with biological activities in Bpertussis
. International Symposium on Pertussis94–98ManclarkC. R.,
HillJ. C.
Washington, DC: DHEW; Publication no. (NIH) 79-1830
WardlawA. C.,
PartonR.,
HookerM. J.1976; Loss of protective antigen, histamine-sensitizing factor and envelope polypeptides in cultural variants of Bordetella pertussis
. Journal of Medical Microbiology 9:89–100